Independent · Evidence-led · We don't sell peptides
EU / NordicsUpdated weeklyEN

Blog

Daily evidence-led peptide research, regulatory news, expert digest and explainers. Every claim sourced; no AI tells.

Page 9

Trial readouts

Semaglutide and CKD Valve Calcification

A multi-method preclinical study linked SIRT1 loss to CKD-related valve calcification and found a semaglutide signal in cells and mice.

5 Oct 2026 · PeptideMethods Editorial Team · 6 min read
Trial readouts

Tirzepatide Cardiac Mouse Study

A mouse and cell study linked tirzepatide with less cardiac microvascular injury, while leaving PRKN dependence and human relevance unresolved.

5 Oct 2026 · PeptideMethods Editorial Team · 4 min read
Trial readouts

Tirzepatide and Treatment Simplification

A 12-month Japanese study linked tirzepatide with more diabetes treatment simplification than conventional GLP-1 medicines, but it was retrospective.

5 Oct 2026 · PeptideMethods Editorial Team · 4 min read
Trial readouts

Tirzepatide and Sleep Apnea Endotypes

A single SURMOUNT-OSA participant had major changes in sleep apnea and airway physiology after tirzepatide, but one case cannot establish mechanism.

5 Oct 2026 · PeptideMethods Editorial Team · 4 min read
Explainer

Cardiovascular and liver care gaps

A new review examines how access barriers can shape cardiovascular and metabolic liver disease care, including selected MASH treatments.

4 Oct 2026 · PeptideMethods Editorial Team · 4 min read
Explainer

GLP-1 drugs and hidradenitis suppurativa

A Danish cohort found more GLP-1 receptor agonist use in hidradenitis suppurativa, but it did not establish a direct treatment benefit.

4 Oct 2026 · PeptideMethods Editorial Team · 4 min read
Explainer

A Heart Failure AI Comment, Explained

A new heart failure comment discusses advanced imaging and AI, but its PubMed record does not establish a semaglutide finding.

4 Oct 2026 · PeptideMethods Editorial Team · 4 min read
Explainer

Incretin Care in Cardiology: Study Findings

A single cardiology program tracked incretin prescribing in high-risk patients. Its results describe routine care, not proof of treatment effects.

4 Oct 2026 · PeptideMethods Editorial Team · 4 min read
Explainer

Medicare prescription payment plans

A modelling study shows when Medicare prescription payment plans may smooth Part D costs and when later bills can become more concentrated.

4 Oct 2026 · PeptideMethods Editorial Team · 5 min read
Explainer

PT-141 Headache and Congestion

Headache and nasal congestion appeared in Vyleesi trials, but a forum report cannot diagnose an individual reaction or verify a PT-141 product.

4 Oct 2026 · PeptideMethods Editorial Team · 4 min read
Explainer

Semaglutide Before Surgery: What to Ask

Semaglutide can affect stomach emptying before anesthesia. Your surgical and prescribing teams need the full medication history, symptoms, and dose changes.

4 Oct 2026 · PeptideMethods Editorial Team · 4 min read
Explainer

A semaglutide accomplishment in context

A Wegovy user's story about kneeling comfortably again is meaningful, but a community post cannot establish a treatment effect for others.

4 Oct 2026 · PeptideMethods Editorial Team · 5 min read